Stock Events

Stock Events

IMV 

$0.82
24
-$0.02-2.55% Friday 20:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
7.86M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

29
SEP
Dividend Ex
 
29
SEP 27
Dividend Ex
Estimated
 

Dividends

0%Dividend Yield
Dec 25
$0.2
Dec 24
$0.14
Dec 23
$0.08
Dec 22
$0.07
Dec 21
$0.09
10Y Growth
15.67%
5Y Growth
24.57%
3Y Growth
35.72%
1Y Growth
N/A

Earnings

8MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
11.96
23.7
35.44
47.18
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
0Revenue
-37.99MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IMV. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap10.61B
Moderna, Inc. is a competitor because it also focuses on mRNA technology for developing vaccines and therapeutics, similar to IMV's delivery platform for immunotherapies.
BioNTech
BNTX
Mkt Cap24.99B
BioNTech SE operates in the same space as IMV, developing and commercializing immunotherapies for cancer and other serious diseases, including mRNA-based vaccines.
Novavax
NVAX
Mkt Cap1.36B
Novavax, Inc. competes with IMV in the development of vaccines for infectious diseases, using its nanoparticle vaccine technology.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is a broad-based competitor, involved in the development of vaccines and therapeutics, including its partnership with BioNTech on a COVID-19 vaccine, competing with IMV's infectious disease focus.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson is involved in the research and development of vaccines and therapeutics for infectious diseases, making it a competitor in the same market as IMV.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences, Inc. competes with IMV in the development of therapeutics for infectious diseases and cancer, with a focus on antiviral drugs.
AMGEN
AMGN
Mkt Cap160.66B
Amgen Inc. competes in the biotechnology space, focusing on innovative therapeutics, including immunotherapies, which puts it in competition with IMV.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals, Inc. is known for its development of monoclonal antibodies for the treatment of cancer and infectious diseases, competing with IMV's focus areas.
Novartis
NVS
Mkt Cap237.61B
Novartis AG competes with IMV in the development of novel healthcare solutions, including vaccines and cancer therapies, through its extensive research and development efforts.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca PLC competes in the development of vaccines and therapeutics for infectious diseases and cancer, overlapping with IMV's research and development focus.

About

Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing
IMV, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of immunotherapies for the treatment of infectious diseases. The company is headquartered in Dartmouth, Nova Scotia and currently employs 51 full-time employees. The Company’s drug delivery platform (DPX) enables the programming of immune cells in vivo. The Company’s lead candidate, DPX-Survivac, is a T cell-activating immunotherapy combining DPX with a specific tumor target: Survivin. DPX-Survivac is a monotherapy in ovarian cancer and in combination with Merck's Keytruda across multiple cancer indications.
Show more...
CEO
Employees
77
Country
CA
ISIN
CA44974L1031

Listings

OTC Link
US
IMVIF
TSE
JP
7760.TSE

0 Comments

Share your thoughts

FAQ

What is IMV stock price today?▼
The current price of IMV is $0.82 USD — it has decreased by -2.55% in the past 24 hours. Watch IMV stock price performance more closely on the chart.
What is IMV stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange IMV stocks are traded under the ticker IMV.
What is IMV market cap?▼
Today IMV has the market capitalization of 7.86M
What is IMV revenue for the last year?▼
IMV revenue for the last year amounts to 0 USD.
What is IMV net income for the last year?▼
IMV net income for the last year is -37.99M USD.
How many employees does IMV have?▼
As of April 01, 2026, the company has 77 employees.
In which sector is IMV located?▼
IMV operates in the Manufacturing sector.
When did IMV complete a stock split?▼
The last stock split for IMV was on December 13, 2022 with a ratio of 1:10.